SPINK5 (serine peptidase inhibitor Kazal type 5)

2007-02-01  

Identity

HGNC
LOCATION
5q32
LOCUSID
ALIAS
LEKTI,LETKI,NETS,NS,VAKTI
FUSION GENES

Other Information

Locus ID:

NCBI: 11005
MIM: 605010
HGNC: 15464
Ensembl: ENSG00000133710

Variants:

dbSNP: 11005
ClinVar: 11005
TCGA: ENSG00000133710
COSMIC: SPINK5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000133710ENST00000256084Q9NQ38
ENSG00000133710ENST00000359874Q9NQ38
ENSG00000133710ENST00000398454Q9NQ38
ENSG00000133710ENST00000476697E5RFU9
ENSG00000133710ENST00000508733E7EWP9
ENSG00000133710ENST00000521206E5RG22

Expression (GTEx)

0
500
1000
1500

Pathways

PathwaySourceExternal ID
Developmental BiologyREACTOMER-HSA-1266738
KeratinizationREACTOMER-HSA-6805567
Formation of the cornified envelopeREACTOMER-HSA-6809371

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
370713032024Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.3
383169202024Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways.0
384429442024SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity.0
370713032024Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.3
383169202024Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways.0
384429442024SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity.0
327096762021Otitis media susceptibility and shifts in the head and neck microbiome due to SPINK5 variants.14
327096762021Otitis media susceptibility and shifts in the head and neck microbiome due to SPINK5 variants.14
314073782020Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.4
325646792020MiR-375-3p alleviates the severity of inflammation through targeting YAP1/LEKTI pathway in HaCaT cells.10
326641812020Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis.3
314073782020Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.4
325646792020MiR-375-3p alleviates the severity of inflammation through targeting YAP1/LEKTI pathway in HaCaT cells.10
326641812020Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis.3
308016722019LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.3

Citation

Dessen P

SPINK5 (serine peptidase inhibitor Kazal type 5)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43889